Drugs / Bifidobacteri
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02097394 Comparator | Jun 2013 → Jun 2020 | infection caused by Bifidobacterium, polyp of colon | RenJi Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bifidobacteri | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02097394 ↗ |
| Modality | Other / unclassified | “intestinal flora drugs(Bifidobacteria)” NCT02097394 ↗ |
| Route | Oral | “Bifidobacteri (2 tablet, po, tid)” NCT02097394 ↗ |